share

Mammalian Ste20-Like Protein Kinase 1 Inhibitor CAS NO 1396771-17-7


Unit Price:

CAS No.:1396771-17-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Mammalian Ste20-Like Protein Kinase 1 Inhibitor CAS NO 1396771-17-7 is a potent and selective small molecule inhibitor designed to target the MST1/STK4 kinase, a key regulator of the Hippo signaling pathway involved in cell proliferation, apoptosis, and organ size control. This compound is essential for researchers and developers in the life sciences sector seeking to modulate this critical pathway for therapeutic discovery and basic biological research. It is primarily utilized in pharmaceutical R&D, academic research, and biotechnology applications focused on oncology, immunology, and regenerative medicine.

Application

  • Pharmaceutical Research & Development: Serves as a critical tool compound for target validation and lead optimization in drug discovery programs targeting cancers and inflammatory diseases.
  • Academic & Basic Research: Used to elucidate the functional role of the Hippo signaling pathway in cellular processes like apoptosis, proliferation, and differentiation.
  • Biochemical Assay Development: Employed as a reference standard in high-throughput screening (HTS) and enzymatic assays to identify and characterize novel MST1 inhibitors.
  • Cell Biology Studies: Applied in vitro to study the effects of MST1 inhibition on cell fate decisions, immune cell function, and tissue regeneration models.
  • Preclinical Disease Modeling: Utilized in animal models to investigate the therapeutic potential of MST1 pathway modulation in oncology and autoimmune disorders.

Basic Information

Product Name Mammalian Ste20-Like Protein Kinase 1 Inhibitor
CAS No. 1396771-17-7
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms MST1 Inhibitor; STK4 Inhibitor; Mammalian STE20-like kinase 1 Inhibitor; Hippo Pathway Inhibitor; CAS 1396771-17-7; 4-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)phenyl)quinazoline (core structural analog); Protein Kinase MST1 Inhibitor
EINECS Contact for details

Quality Control

Our Mammalian Ste20-Like Protein Kinase 1 Inhibitor is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity assessment and NMR/LC-MS for structural confirmation, to ensure high chemical and biological consistency. Certificates of Analysis (COA) detailing purity, identity, and potency are provided with every shipment to support your research integrity and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry, moisture-free environment. The product is hygroscopic (moisture-sensitive) and light-sensitive. Allow the vial to equilibrate to room temperature before opening to minimize moisture absorption.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms to reference standard
Identification (MS) Conforms to structure
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 1.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.